While our current study reports that two weeks of elevated circulating IL-6 was not sufficient to reduce muscle mitochondrial content, the IL-6r antibody treatment after the initiation of cachexia was able to significantly attenuate the loss of mitochondria. The gene discussed is IL6R; the disease is Cachexia.